top
Articles
  • OpenAccess
  • The Results Observation on Adjuvant Chemotherapy with Microwave Hyperthermia and Stereotactic Radiotherapy in Retreated Elderly Patients with Advanced (III/IV Stage) Lung Cancer  [ICMTT 2016]
  • DOI: 10.4236/jbm.2016.43013   PP.75 - 78
  • Author(s)
  • Xihao Yu, Xinping Li, Guiyun Dong, Wenyan Yu, Jianping Wang, Ying Xiong
  • ABSTRACT
  • Objective: To evaluate the significance of adjuvant chemotherapy and radiotherapy (Gamma-knife) in the elderly patients with retreated advance lung cancer. Methods 83 patients (age 50 to 81 years) with retreating advanced (III/IV stage) lung cancer were divided into three groups according to patients received treating by different methods. The cases were treated by synchronous chemo-radiotherapy (A group), sequentially chemo-radiotherapy (B group) and continuous systematized chemotherapy alone (C group). The systemic 3-dimensional orientation apparatus was used in radiotherapy. The chemotherapy regimen in combined radiotherapy was given by common first line regimen on lung cancer. The regimen of chemotherapy combated with whole body hyperthermia by using micro-wave on abodeman about 2 or 3 line was used in C group only. Results: The overall responses rates (RR) of A, B and C groups were 17.1%, 11.5% and 31.8%, but it was non-significance difference (P > 0.05). Overall responses rates (RR) of III and IV stage groups were 18.2% and 20.0%. The average overall survival time (OS) and median survival time (MST) of the patients treated by chemotherapy (C group) were highest about 14.2 and 9.3 months (respectively at A group 6.7 and 6.0 months. P < 0.01), in which B group was longer than A group (P < 0.05), and 95.5% CI value was not overlap. The total survival time of postoperative patients was longer in the various groups by different treated than that in non-operations. Conclusion: The rates (RR) of III and IV stage groups were non-significance difference. The higher of ORR, OS and MST in a few patients of re-treated advanced lung cancer was presented in case with treated by continuous system chemotherapy. There were survival superiority in initial postoperative patients groups by different treated. It is a profitable and effect treatment that the pure reasonable systemic chemotherapy was used for elderly case with advanced retreated lung cancer.

  • KEYWORDS
  • Elderly Patients, Chemotherapy, Combined Radiotherapy, Lung Cancer
  • References
  • [1]
    Lin, J.-C., Jan, J.-S., Hsu, C.-Y., et al. (2003) Phase 3 Study of Concurrent Chemoradiotherapy versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival. Journal of Clinical Oncology, 21, 631-637.
    http://dx.doi.org/10.1200/JCO.2003.06.158
    [2]
    Mehta, M., Scrimger, R., Mackkie, R., et al. (2001) A New Approach to Dose Escalation in Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 49, 23-33.
    http://dx.doi.org/10.1016/S0360-3016(00)01374-2
    [3]
    Nagai, K., Sohara, Y., Tsachiya, R., et al. (2007) Prognosis of Resectd Non-Small Cell Lung Cancer Patients with Intrapalmonary Metastases. Journal of Thoracic Oncology, 2, 282-286.
    http://dx.doi.org/10.1097/01.JTO.0000263709.15955.8a

Engineering Information Institute is the member of/source content provider to

http://www.scirp.org http://www.hanspub.org/ http://www.crossref.org/index.html http://www.oalib.com/ http://www.ebscohost.com/ http://www.proquest.co.uk/en-UK/aboutus/default.shtml http://ip-science.thomsonreuters.com/cgi-bin/jrnlst/jlresults.cgi?PC=MASTER&Full=journal%20of%20Bioequivalence%20%26%20Bioavailability http://publishers.indexcopernicus.com/index.php